Title:
SUSTAINED RELEASE OSMOTIC-CONTROLLED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/083087
Kind Code:
A1
Abstract:
A sustained release osmotic-controlled pharmaceutical composition is provided, including: a core and a semi-permeable membrane coated on the core. The core includes a drug compartment, in which the drug compartment includes a first active ingredient, a first polymer and a first osmogen, and the first active ingredient includes lurasidone, a pharmaceutical acceptable salt of the lurasidone or a combination thereof. The semi-permeable membrane includes a membrane body and at least one pore distributed in the membrane body.
Inventors:
LIOU CHUN-YOU (CN)
CHAN TZU-HSIEN (CN)
JHAN HUA-JING (CN)
LIU I-HSIANG (CN)
CHEN TSE-HSIEN (CN)
JIAN CHI-HENG (CN)
CHAN TZU-HSIEN (CN)
JHAN HUA-JING (CN)
LIU I-HSIANG (CN)
CHEN TSE-HSIEN (CN)
JIAN CHI-HENG (CN)
Application Number:
PCT/CN2023/124810
Publication Date:
April 25, 2024
Filing Date:
October 16, 2023
Export Citation:
Assignee:
ANXO PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K9/36; A61K9/24; A61K31/496; A61K47/02; A61K47/10; A61P25/18
Domestic Patent References:
WO2021014360A1 | 2021-01-28 |
Foreign References:
CN110693843A | 2020-01-17 | |||
CN114601813A | 2022-06-10 | |||
US20140343076A1 | 2014-11-20 | |||
CN102283817A | 2011-12-21 | |||
US20080089937A1 | 2008-04-17 |
Attorney, Agent or Firm:
LUNG TIN INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF:
Previous Patent: BICYCLIC DERIVATIVE INTEGRIN INHIBITOR
Next Patent: MANIFOLD STRUCTURE AND DRUG FEEDER HAVING SAME
Next Patent: MANIFOLD STRUCTURE AND DRUG FEEDER HAVING SAME